Meningioangiomatosis
| Meningioangiomatosis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Seizures, headache, focal neurological deficits |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Unknown, possibly genetic |
| Risks | |
| Diagnosis | MRI, CT scan, biopsy |
| Differential diagnosis | Meningioma, glioma, tuberculoma |
| Prevention | |
| Treatment | Surgical resection, anticonvulsants |
| Medication | |
| Prognosis | Generally good with complete resection |
| Frequency | Rare |
| Deaths | N/A |
Meningioangiomatosis is a rare, benign, hamartomatous lesion of the central nervous system (CNS). It is characterized by a proliferation of meningothelial cells, blood vessels, and neural elements. The condition is often associated with neurofibromatosis type 2 (NF2), but can also occur sporadically.
Clinical Presentation[edit]
Patients with meningioangiomatosis often present with seizures, headache, and focal neurological deficits. The age of onset varies, but the condition is most commonly diagnosed in children and young adults.
Pathology[edit]
Meningioangiomatosis is characterized by a proliferation of meningothelial cells, blood vessels, and neural elements. The lesion is often located in the cerebral cortex and leptomeninges, but can also occur in the spinal cord. Histologically, the lesion resembles a meningioma, but with a more complex architecture.
Diagnosis[edit]
The diagnosis of meningioangiomatosis is typically made based on histopathological examination of a biopsy specimen. Magnetic resonance imaging (MRI) can also be helpful in the diagnosis, as the lesion often shows a characteristic appearance on imaging.
Treatment[edit]
The treatment of meningioangiomatosis typically involves surgical resection of the lesion. In some cases, antiepileptic drugs may also be used to control seizures.
Prognosis[edit]
The prognosis for patients with meningioangiomatosis is generally good, as the lesion is benign and often responds well to treatment. However, the condition can be associated with significant morbidity due to seizures and other neurological deficits.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
